🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

Incredibly impressed by the accomplishments and rigorous research done by our EmREACH scholars! Major kudos to Nikesha Gilmore, PhD (she/her/hers) who is the driving force behind this program!

Here we go! Kicked off #ASCO23 with some excited collaborative AYA sessions, can’t wait to see what else the weekend brings!

Today is the day! SWOG Cancer Research Network 1826 data will be presented at ASCO plenary, with discussion from Ann LaCasce, MD meetings.asco.org/abstracts-pres…

Interesting work on S100B and cognitive decline in breast cancer presented by Aaron Huynh ! Very proud to have mentored you alongside Michelle Janelsins,PhD,MPH during your PREP program URochester SMD ! And very excited for all you will accomplish in the future!

Congratulations Jamie Flerlage ! Cannot wait to work more closely with you and tackle survivorship issues in pediatric and AYA lymphoma!

Starting the next session AnnaLynn Williams, PhD on why 5 year survival rates aren’t the only metric that need improving #AYACancerCongress

Dr. AnnaLynn Williams, PhD (University of Rochester URMC Department of Medicine Wilmot Cancer Institute) INCREDIBLE presentation: “Rethinking Success in Pediatric and Adolescent Cancer: Beyond 5-year Survival” #Ayacsm Global AYA Cancer Congress

My absolute honor to present to the #globalayacancercongress these sobering results on excess deaths 10 or more years from diagnosis in Survivors of AYA cancers. Humbled by the support and energy in this room from colleagues, patient advocates, and community organizations!

Thank you to 13thirty Cancer Connect and the D’Amanda family for this honor! I am looking forward to the great work we will be able to do together!

My lab is looking to hire a Human Subject Research Coordinator 2 to coordinate studies involving children, adolescents and young adults with cancer, apply now! and help spread the word! JOBID: 243108 #ayacsm Wilmot Cancer Institute rochester.edu/human-resource…

By far my favorite session so far at #ASH23 has been the Promoting Minorities in Hematology Oral Presentations!! I am in awe of these amazing early investigators & their work! So many unique, novel & interesting questions/data! These are the new ideas needed to change care!

🗒️ #JCO #Review: Psychological Outcomes in Adolescent and Young Adult Cancer Survivors 💡Interventions should consider multiple levels of influence Read more ➡️ brnw.ch/21wFFqY #AYACSM #psyonc Tara Brinkman, PhD Meghan McGrady, PhD AnnaLynn Williams, PhD victoria w willard, phd

Honored to present our work using GAP70+ data at #ASCO24: Geriatric assessment guided tx modification improved tolerability in older adults with advanced cancer compared to oncologist’s estimate only. More work is needed to optimize chemo dosing in this population Wilmot Cancer Institute

Great highlights. So proud of our team! #ASCO24

Proud of UR NCI T32 early career investigator Dr Mattick for her work assessing walking minutes/week needed for meaningful reductions in cancer-related fatigue.@kmustian The Peppone Lab Nikesha Gilmore, PhD (she/her/hers) AnnaLynn Williams, PhD Charles Kamen Jeremy McGuire @DrPJLin URMC Department of Surgery Wilmot Cancer Institute

Congratulations to Tianming Zhao on his first #ASCO2024 poster demonstrating unique and heterogenous trajectories of cognitive function after treatment for non Hodgkin lymphoma! Wilmot Cancer Institute Michelle Janelsins,PhD,MPH #firstphdmentee

Congratulations Lauren Ghazal, PhD, FNP-BC on this recognition that is so well deserved!!

Join Drs Nikesha Gilmore, PhD (she/her/hers) , Judith Carroll and I as we discuss epigenetic aging in cancer patients and survivors on June 20th! Wilmot Cancer Institute

Thank you David Hodgson for the invitation and opportunity to present to and learn from this amazing group! #pogoaftercareEdDay

Longitudinal Health-Related Quality of Life Among Patients With High-Risk Pediatric Hodgkin Lymphoma Treated on the AHOD 1331 Study | AnnaLynn Williams, PhD Journal of Clinical Oncology ascopubs.org/doi/10.1200/JC…